| Literature DB >> 31834123 |
Neil R Poulter1, Claudio Borghi2, Gianfranco Parati3,4, Atul Pathak5,6, Diana Toli7, Bryan Williams8, Roland E Schmieder9.
Abstract
: Suboptimal adherence to antihypertensive medication is a major contributor to poor blood pressure control. Several methods, direct or indirect, are available for measuring adherence, including the recently developed biochemical screening, although there is no gold-standard method routinely used in clinical practice to accurately assess the different facets of adherence. Adherence to treatment is a complex phenomenon and several of the barriers to adherence will need to be addressed at the healthcare system level; however, when looking at adherence from a more practical side and from the practitioner's perspective, the patient-practitioner relationship is a key element both in detecting adherence and in attempting to choose interventions tailored to the patient's profile. The use of single-pill combinations enabling simplification of treatment regimen, the implementation of a collaborative team-based approach and the development of electronic health tools also hold promise for improving adherence, and thus impacting cardiovascular outcomes and healthcare costs.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31834123 DOI: 10.1097/HJH.0000000000002294
Source DB: PubMed Journal: J Hypertens ISSN: 0263-6352 Impact factor: 4.844